(1) Complex (epi-)genetic editing for enhanced recombinant protein production
(2) Genome editing to enable functional prediction of drug resistance in tumours
(3) Viral delivery of complex genome editing systems in primary cells
At AstraZeneca, we believe in the potential of people with passion for science.
You will work with our global postdoctoral community and high-profile external collaborators (Sanger Institute, Harvard, MIT, UC Berkeley, UCSF, University of Bristol, University of Edinburgh, University of Manchester and Imperial College).
For more information contact: Emanuela.Cuomo@astrazeneca.com
Apply today on the AstraZeneca website or follow the link: